NISUY yields 1.03% · JNJ yields 2.13%● Live data
📍 NISUY pulled ahead of the other in Year 1
Combined, NISUY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NISUY + JNJ for your $10,000?
Nissui Corporation engages in marine, food products, fine chemicals, distribution, and marine-related/engineering businesses in Japan and internationally. The company engages in the provision of salmon, Alaska pollock, yellowtail, shrimp, tuna, crab, and yellowtail products, as well as fish feed, oil, and meal products. It also produces and sells frozen foods for household and food service use, shelf-stable foods, and fish sausage and surimi-based products, as well as chilled foods. In addition, the company produces and supplies fine chemical products, such as eicosapentaenoic acid (EPA) for pharmaceuticals; and ingredients for functional foods, health products, supplements, and other health-related foods that contain EPA. Further, it is involved in integrated logistics service business; and building, repairing, and operating ships. The company was formerly known as Nippon Suisan Kaisha, Ltd. and changed its name to Nissui Corporation in December 2022. The company was founded in 1911 and is headquartered in Tokyo, Japan.
Full NISUY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.